Genetic Technologies Limited (NASDAQ:GENE) is a $9.9 million organization. That pales – considerably – in comparison to $1.15 billion Genomic Health, and is downright dwarfed by $2.8 billion Myriad Genetics. That small size alone is alarming to newcomers – never even mind the fact that GENE shares have fallen 73% over the past twelve months. As they say, though, nothing lasts forever, and it looks … Continue reading Top News: Genetic Technologies Limited (NASDAQ:GENE), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Sovran Self Storage Inc. (NYSE:SSS), Evercore Partners Inc. (NYSE:EVR), MagnaChip Semiconductor (NYSE:MX)